Literature DB >> 13780684

Streptomycin plus pyrazinamide in the treatment of patients excreting isonazid-resistant tubercle bacilli, following previous chemotherapy.

S VELU, R H ANDREWS, J H ANGEL, S DEVADATTA, W FOX, P G JACOB, C N NAIR, C V RAMAKRISHNAN.   

Abstract

Entities:  

Keywords:  ANTITUBERCULAR AGENTS/therapy

Mesh：

Substances：

Year:  1961        PMID： 13780684     DOI： 10.1016/s0041-3879(61)80089-5

Source DB:  PubMed          Journal:  Tubercle        ISSN： 0041-3879


× No keyword cloud information.
  9 in total

1.  PROLONGED STREPTOMYCIN AND ISONIAZID FOR PULMONARY TUBERCULOSIS.

Authors:  R N JOHNSTON; D H SMITH; R T RITCHIE; W LOCKHART
Journal:  Br Med J       Date:  1964-06-27

2.  Tuberculosis in the elderly.

Authors:  W FOX
Journal:  Br Med J       Date:  1963-03-02

3.  Tuberculosis in an African setting. The therapeutic problem.

Authors:  P W HUTTON
Journal:  Postgrad Med J       Date:  1962-02       Impact factor: 2.401

4.  Clinical and toxicodynamic evidence that high-dose pyrazinamide is not more hepatotoxic than the low doses currently used.

Authors:  Jotam G Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2010-05-03       Impact factor: 5.191

5.  Concentrations of pyrazinamide attained in serum with different doses of the drug.

Authors:  S Subbammal; D V Krishnamurthy; S P Tripathy; P Venkataraman
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

6.  New responsibilities for health departments and public health nurses in tuberculosis-- keeping the outpatient on therapy.

Authors:  T Moulding
Journal:  Am J Public Health Nations Health       Date:  1966-03

7.  A 5-year study of patients with pulmonary tuberculosis in a concurrent comparison of home and sanatorium treatment for one year with isoniazid plus PAS.

Authors:  J J Dawson; S Devadatta; W Fox; S Radhakrishna; C V Ramakrishnan; P R Somasundaram; H Stott; S P Tripathy; S Velu
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

8.  A 5-year study of patients with pulmonary tuberculosis treated at home in a controlled comparison of isoniazid plus PAS with 3 regimens of isoniazid alone.

Authors:  C Evans; S Devadatta; W Fox; P R Gangadharam; N K Menon; C V Ramakrishnan; S Sivasubramanian; P R Somasundaram; H Stott; S Velu
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

9.  Toxicity of pyrazinamide, administered once weekly in high dosage, in tuberculous patients.

Authors:  C V Ramakrishnan; B Janardhanam; D V Krishnamurthy; H Stott; S Subbammal; S P Tripathy
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.